Inovio Pharmaceuticals INO
NASDAQ INO
$1.41 -0.06 (-4.08%)
As of: Nov 12, 2026 · 9:38 AM EST

Inovio Pharmaceuticals (INO) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Inovio Pharmaceuticals' Return on Capital Employed [ROCE] came in at -819.81% for Q2 2026, down 611.66 percentage points from -208.15% a year earlier and down 472.72 percentage points from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Inovio Pharmaceuticals' Return on Capital Employed [ROCE] was -173.35%, down 68.06 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -132.01 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -105.29% in FY2024 (-39.01 pp), -66.28% in FY2023 (+15.96 pp), -82.24% in FY2022 (-15.61 pp) and -66.62% in FY2021 (-25.28 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of -166.83 percentage points over the last seven quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2023 (a gain of 18.93 percentage points), and the weakest in Q2 2026 (a drop of 611.66 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Inovio Pharmaceuticals 143.02 Mn -38.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -819.81%
Mar 31, 2026 -347.10%
Dec 31, 2025 -308.11%
Jun 30, 2025 -208.15%
Mar 31, 2025 -145.34%
Dec 31, 2024 -150.26%
Sep 30, 2024 -123.21%
Jun 30, 2024 -121.49%
Mar 31, 2024 -103.82%
Dec 31, 2023 -103.22%
Sep 30, 2023 -101.85%
Jun 30, 2023 -87.27%
Mar 31, 2023 -95.00%
Dec 31, 2022 -97.88%
Sep 30, 2022 -95.88%
Jun 30, 2022 -106.20%
Mar 31, 2022 -77.89%
Dec 31, 2021 -66.92%
Sep 30, 2021 -43.92%
Jun 30, 2021 -35.24%
API Access

Inovio Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INO&period=max&api_key=YOUR_API_KEY